TRICC-C (AIO-KRK-0111): BIBF 1120 Versus Placebo in Patients Receiving Oxaliplatin Plus Fluorouracil and Leucovorin (mFOLFOX6) for Advanced, Chemorefractory Metastatic Colorectal Cancer (mCRC)

NCT01362361 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: mFOLFOX6 + BIBF 1120
DRUG: mFOLFOX6+placebo

Sponsor

Martin-Luther-Universität Halle-Wittenberg

Collaborators

[object Object]